Thus, we decided to study the expression of these two nuclear transcription factors involved in metabolic reprogramming of cancer cells and our data showed that resistant cells are characterized by higher levels of HIF-1α and lower levels of c-MYC (Fig. 3E–H). The gene discussed is HIF1A; the disease is cancer.